Ascom Holding AG

SWX:ASCN Stock Report

Market Cap: CHF 136.9m

Ascom Holding Valuation

Is ASCN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ASCN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CHF 8.66
Fair Value
56.0% undervalued intrinsic discount
2
Number of Analysts

Below Fair Value: ASCN (CHF3.81) is trading below our estimate of fair value (CHF8.66)

Significantly Below Fair Value: ASCN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ASCN?

Key metric: As ASCN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ASCN. This is calculated by dividing ASCN's market cap by their current earnings.
What is ASCN's PE Ratio?
PE Ratio45.6x
EarningsCHF 3.00m
Market CapCHF 136.85m

Price to Earnings Ratio vs Peers

How does ASCN's PE Ratio compare to its peers?

The above table shows the PE ratio for ASCN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.3x
CLTN COLTENE Holding
18.6x17.44%CHF 266.5m
VBSN IVF Hartmann Holding
16.2xn/aCHF 328.6m
6569 Onyx Healthcare
39.6xn/aNT$4.9b
2361 Sinohealth Holdings
14.8xn/aHK$1.5b
ASCN Ascom Holding
45.6x40.36%CHF 136.9m

Price-To-Earnings vs Peers: ASCN is expensive based on its Price-To-Earnings Ratio (45.6x) compared to the peer average (22.2x).

Price to Earnings Ratio vs Industry

How does ASCN's PE Ratio compare vs other companies in the European Healthcare Services Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
ASCN 45.6xIndustry Avg. 39.2xNo. of Companies2PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ASCN is expensive based on its Price-To-Earnings Ratio (45.6x) compared to the Global Healthcare Services industry average (39.3x).

Price to Earnings Ratio vs Fair Ratio

What is ASCN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ASCN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio45.6x
Fair PE Ratio36.4x

Price-To-Earnings vs Fair Ratio: ASCN is expensive based on its Price-To-Earnings Ratio (45.6x) compared to the estimated Fair Price-To-Earnings Ratio (36.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ASCN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 3.81
CHF 5.28
+38.45%
28.91%CHF 6.80CHF 3.75n/a2
Oct ’26CHF 3.54
CHF 5.28
+49.22%
28.91%CHF 6.80CHF 3.75n/a2
Sep ’26CHF 4.58
CHF 5.28
+15.30%
28.91%CHF 6.80CHF 3.75n/a2
Aug ’26CHF 4.11
CHF 5.23
+27.28%
28.23%CHF 6.70CHF 3.75n/a2
Jul ’26CHF 3.65
CHF 5.23
+43.35%
28.23%CHF 6.70CHF 3.75n/a2
Jun ’26CHF 3.73
CHF 5.23
+40.27%
28.23%CHF 6.70CHF 3.75n/a2
May ’26CHF 3.22
CHF 5.23
+62.27%
28.23%CHF 6.70CHF 3.75n/a2
Apr ’26CHF 3.33
CHF 5.23
+56.91%
28.23%CHF 6.70CHF 3.75n/a2
Mar ’26CHF 3.79
CHF 4.73
+24.67%
20.63%CHF 5.70CHF 3.75n/a2
Feb ’26CHF 3.46
CHF 5.50
+59.19%
3.64%CHF 5.70CHF 5.30n/a2
Jan ’26CHF 4.16
CHF 6.65
+59.86%
20.30%CHF 8.00CHF 5.30n/a2
Dec ’25CHF 4.16
CHF 6.65
+59.86%
20.30%CHF 8.00CHF 5.30n/a2
Nov ’25CHF 4.85
CHF 6.65
+37.25%
20.30%CHF 8.00CHF 5.30n/a2
Oct ’25CHF 5.42
CHF 9.67
+78.35%
24.38%CHF 13.00CHF 8.00CHF 3.543
Sep ’25CHF 5.60
CHF 9.67
+72.62%
24.38%CHF 13.00CHF 8.00CHF 4.583
Aug ’25CHF 6.34
CHF 11.17
+76.13%
20.14%CHF 13.00CHF 8.00CHF 4.113
Jul ’25CHF 7.67
CHF 12.17
+58.63%
6.98%CHF 13.00CHF 11.00CHF 3.653
Jun ’25CHF 8.11
CHF 12.17
+50.02%
6.98%CHF 13.00CHF 11.00CHF 3.733
May ’25CHF 7.40
CHF 12.17
+64.41%
6.98%CHF 13.00CHF 11.00CHF 3.223
Apr ’25CHF 8.23
CHF 12.17
+47.83%
6.98%CHF 13.00CHF 11.00CHF 3.333
Mar ’25CHF 7.45
CHF 13.00
+74.50%
10.88%CHF 14.00CHF 11.00CHF 3.793
Feb ’25CHF 7.27
CHF 13.00
+78.82%
10.88%CHF 14.00CHF 11.00CHF 3.463
Jan ’25CHF 8.22
CHF 13.00
+58.15%
10.88%CHF 14.00CHF 11.00CHF 4.163
Dec ’24CHF 10.52
CHF 15.22
+44.65%
2.01%CHF 15.65CHF 15.00CHF 4.163
Nov ’24CHF 9.56
CHF 15.72
+64.40%
3.91%CHF 16.50CHF 15.00CHF 4.853
Oct ’24CHF 10.40
CHF 15.72
+51.12%
3.91%CHF 16.50CHF 15.00CHF 5.423
CHF 5.28
Fair Value
27.8% undervalued intrinsic discount
2
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/07 12:15
End of Day Share Price 2025/10/07 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ascom Holding AG is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stefan GächterBaader Helvea Equity Research
Michael StuderBank am Bellevue
Serge RotzerBank Vontobel AG